Abbott director awarded 416 stock equivalent units

Roman Michael F reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Roman Michael F reported acquisition or exercise transactions in this Form 4 filing.

ABBOTT LABORATORIES director Michael F. Roman received a grant of 416 stock equivalent units as compensation. These units were credited on 2026-06-30 at a reference price of $90.74 per unit and are tied to director fees.

The stock equivalent units track the return Abbott shares would have earned, but are paid out in cash, generally at age 65 or when the director retires from the board. After this award, Roman holds a total of 6,746 stock equivalent units, including amounts accumulated through a dividend reinvestment feature.

Insider Trade Summary

Grant/Award: 416 shares

Grant/Award 1 txn

Insider Roman Michael F

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Equivalent Units	416	$90.74	$38K

Holdings After Transaction: Stock Equivalent Units — 6,746 contracts (Direct)

Footnotes (2)

1. F1. Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
2. F2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Key Figures

Stock equivalent units granted: 416 units Reference price per unit: $90.74 per unit Total units after grant: 6,746 units +1 more

4 metrics

Stock equivalent units granted 416 units Grant to director on 2026-06-30

Reference price per unit $90.74 per unit Stock equivalent unit grant value reference

Total units after grant 6,746 units Director’s stock equivalent unit balance after transaction

Underlying common shares 416 shares Underlying ABBOTT LABORATORIES common shares referenced by units

Key Terms

Stock Equivalent Units, dividend reinvestment feature, director fees

3 terms

Stock Equivalent Units financial

"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board."

Stock equivalent units are financial claims or instruments that are treated as if they were actual shares for purposes like calculating ownership, dilution, and earnings per share. Think of them as promises or placeholders for future slices of company pie—options, restricted units, or convertible securities—that don’t yet sit on the table but will reduce each existing slice when converted. Investors track them because they change how much of a company each share really represents and can affect valuation and voting power.

dividend reinvestment feature financial

"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature."

director fees financial

"Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ABBOTT LABORATORIES (ABT) report for Michael F. Roman?

ABBOTT LABORATORIES reported that director Michael F. Roman received 416 stock equivalent units as a compensation grant. These units are tied to director fees and mirror Abbott share returns, but are ultimately paid in cash rather than as actual stock.

How many ABBOTT LABORATORIES stock equivalent units does Michael F. Roman hold after this Form 4?

Following the reported grant, Michael F. Roman holds 6,746 stock equivalent units. This balance includes the new 416-unit award and additional units accumulated through a dividend reinvestment feature linked to ABBOTT LABORATORIES share performance.

Are the ABBOTT LABORATORIES stock equivalent units in this Form 4 actual ABT shares?

The reported stock equivalent units are not actual ABT shares. They are bookkeeping units that track ABBOTT LABORATORIES share returns, but are paid in cash, generally at age 65 or upon the director’s retirement from the board, rather than delivered as stock.

What was the reference price for the ABBOTT LABORATORIES stock equivalent unit grant?

The 416 stock equivalent units were credited at a reference price of $90.74 per unit. This price helps determine the value of the compensation tied to ABBOTT LABORATORIES, although the units are ultimately settled in cash, not traded as common shares.

How are dividends handled for Michael F. Roman’s ABBOTT LABORATORIES stock equivalent units?

His balance includes stock equivalent units acquired through a dividend reinvestment feature. When ABBOTT LABORATORIES pays dividends, equivalent amounts are credited as additional stock equivalent units, increasing the total units tracked in his compensation account.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 05:53 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roman Michael F

(Last) (First) (Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Equivalent Units	(1)	06/30/2026		A		416		(1)	(1)	Common Shares	416	$90.74	6,746(2)	D

Explanation of Responses:

1. Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.

2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

	/s/ Michael F. Roman by Jessica H. Paik, Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)